US firm set to snap up Woodford's biotech holdings for $300m - reports
Acacia Research Corporation in talks with Link Fund Solutions
Neil Woodford has also tabled an offer for the portfolio
US-based Acacia Research Corporation is set to acquire a portfolio of biotech holdings owned by Woodford Investment Management for $300m, according to reports.
The portfolio, which comprises assets in the stricken LF Equity Income fund (EIF), includes the likes of Theravance Biopharma, Oxford Nanopore and Rutherford Cancer Centres, according to Sky News. The...
More on Funds
Back to Top
